High incidence of chronic graft versus host disease after allogeneic peripheral blood progenitor cell transplantation

Haematologica

Volumn 82, Issue 6, 1997, Pages 683-689

  Urbano Ispizua, Alvaro ^b   García Conde, Javier ^b   Brunet, Salut ^b   Hernández, Fernando ^b   Sanz, Guillermo ^b   Petit, Josep ^b   Bargay, Joan ^b   Figuera, Angela ^b   Rovira, Montserrat ^b   Solano, Carlos ^b   Ojeda, Emilio ^b   De La Rubia, Javier ^b   Rozman, Ciril ^a  

^a HOSPITAL CLÍNIC   (Spain)

^b NONE

Author keywords

Allogineic transplantation; Chronic GVHD; Peripheral blood progenitor cells

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MALE; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; TREATMENT OUTCOME;

ADOLESCENT; ADULT; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TRANSPLANTATION, HOMOLOGOUS;

EID: 0031468863     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Kessinger A, Smith DM, Strandjord SE, et al. Allogeneic transplantation of blood-derived, T-cell-depleted hemopotetic stem cells after myeloablative treatment in a patient with acute lymphoblastic leukemia. Bone Marrow Transpl 1989; 4:643-6.
2. Russell NH, Hunter A, Rogers S, Hanley J, Anderson D. Peripheral blood stem cells as an alternative to marrow for allogeneic transplantation [letter]. Lancet 1993; 341:1482.
3. Dreger P, Haferlach T, Eckstein V, et al. G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation: safety, kinetics of mobilization, and composition of the graft. Br J Haematol 1994; 87:609-13.
4. Majolino I, Aversa F, Bacigalupo A, Bandini G, Arcese W, Reali G. Allogeneic transplants of rhG-CSF mobilized peripheral blood stem cells from normal donors. GITMO. Haematologica 1995; 80:40-3.
5. Majolino I, Aversa F, Bacigalupo A, Bandini G, Arcese W, Reali G. Peripheral blood stem cells for allogeneic transplantation. Recommendations from the GITMO 1996. Haematologica 1996; 81:529-32.
6. Bensinger WI, Weaver CH, Appelbaum FR, et al. Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor. Blood 1995; 85:1655-8.
7. Schmitz N, Dreger P, Suttorp M, et al. Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor). Blood 1995; 85:1666-72.
8. d+m) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host-disease. Blood 1995; 86:2842-50.
9. Urbano-Ispizua A, Solano C, Brunet S, et al. Allogeneic peripheral blood progenitor cells transplantation: analysis of short-term engraftment and acute GVHD incidence in 33 cases. Bone Marrow Transpl 1996; 18:35-40.
10. Dreger P, Haferlach T, Eckstein V, et al. G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation: safety, kinetics of mobilization, and composition of the graft. Br J Haematol 1994; 87:609-13.
11. Bensinger W, Price TH, Dale DC, et al. The effects of daily recombinant human granulocyte colony-stimulating factor administration on normal granulocyte donors undergoing leukapheresis. Blood 1993; 81:1883-8.
12. Goldman J. Peripheral blood stem cells for allografting. Blood 1995; 85:1413-5.
13. Anderlini P, Przepiorka D, Champlin R, Körbling M. Biologic and clinical effects of granulocyte colony-stimulating factor in normal individuals. Blood 1996; 88:2819-25.
14. Martínez C, Urbano-Ispizua A, Rozman C, et al. Effects of G-CSF administration and peripheral blood progenitor cells collections in 20 healthy donors. Ann Hematol 1996; 72:269-72.
15. Briones J, Urbano-Ispizua A, Rozman C, et al. Study of haemopoietic chimerism following allogeneic peripheral blood stem cell transplantation using PCR-STR. Ann Hematol 1996; 72:265-8.
16. Majolino I, Saglio G, Scimé R, et al. High incidence of chronic GVHD after primary allogeneic peripheral blood stem cell transplantation in patients with hematologic malignancies. Bone Marrow Transpl 1996; 17:555-60.
17. Anderlini P, Przepiorka D, Khouri I, et al. Chronic graft-vs-host disease (GVHD) after allogeneic marrow or blood stem cell transplantation [abstract]. Blood 1995; 86(Suppl 1):108a.
18. Thomas ED, Storb R, Clift RA, et al. Bone marrow transplantation. N Engl J Med 1975; 292:832-43.
19. Dixon WJ, Brown MB, Engelman L, Hill MA, Jenrich RT. BMDP statistical software. Berkeley: University California Press; 1988.
20. García-Conde J, Martín-Gaitero MJ, Arbona C, Benet I, Terol MJ, Solano C. High frecuency of chronic GVHD associated with unmodified allo-PBPCT. Preliminary results of allogeneic CD34+ selected cells PBPCT [abstract]. Blood 1996; 88(Suppl 1):261a.
21. Rosenfeld CS, Weinthl JW, Collins RW, et al. Does CD34 content of allogeneic peripheral blood cell transplants predict acute GVHD? [abstract]. Blood 1996; 88(suppl 1):616a.
22. Schmitz N, Bacigalupo A, Labopin M, et al. Transplantation of allogeneic peripheral blood progenitor cells from HLA-identical sibling donors. Br J Haematol 1996; 95:715-23.
23. Russell JA, Brown C, Bowen T, et al. Allogeneic blood cells transplants for haematological malignancy: preliminary comparison of outcomes with bone marrow transplantation. Bone Marrow Transpl 1996; 17:703-8.
24. Bensinger WI, Clift R, Martin P, et al. Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies: a retrospective comparison with marrow transplantation. Blood 1996; 88:2794-800.
25. Rosenfeld C, Collins R, Pineiro L, Agura E, Nemunaitis J. Allogeneic blood cell transplantation without posttransplant colony-stimulating factors in patients with hematopoietic neoplasm: a phase II study. J Clin Oncol 1996; 14:1314-9.
26. Miflin G, Russell NH, Hutchinson RM, et al. Allogeneic peripheral blood stem cell transplantation for haematological malignancies - an analysis of kinetics of engraftment and GVHD risk. Bone Marrow Transpl 1997; 19:9-13.
27. Bortin MM, for the international bone marrow transplant registry. Factors influencing the risk of acute and chronic graft-versus-host disease in humans: a preliminary report from the IBMTR. Proceedings of Leukemia 1988. Recent progress in biology and clinical research. First advanced international course, November 5-8, 1988. Bone Marrow Transpl 1989; 4(Suppl 1).
28. Dreger P, Glass B, Uharek L, Schmitz N. Allogeneic peripheral blood progenitor cells: current status and future directions. J Hematother 1996; 5:331-7.
29. Krenger W, Ferrara JLM. Dysregulation of cytokines during graft-versus-host disease. J Hematother 1996; 5:3-14.
30. Krenger W, Snyder KM, Byon JHC, et al. Polarized type 2 alloreactive CD4+ and CD8+ donor T cells fail to induce experimental acute graft-versus-host disease. J Immunol 1995; 155:585-93.
31. Pan L, Delmonte J, Jalonen CK, et al. Pretreatment of donor mice with granulocyte colony-stimulating factor polarizes donor T-lymphocytes toward type-2 cytokine production and reduces severity of experimental graft-versus-host disease. Blood 1995; 86:4422-9.
32. Sullivan KM. Graft versus host disease. In: Forman SJ, Blume KG, Thomas ED, eds. Bone Marrow Transplantation. Boston: Blackwell Scientific Publications, 1994. p. 339-62.
33. Bortin MM, Rigden O, Horowitz MM, Rozman C, Weiner RS, Rimm AA. Temporal relationship between the major complications of bone marrow transplantation for leukemia. Bone Marrow Transpl 1989; 4:339-44.
34. Weiden PL, Sullivan KM, Flournoy NF, Storb R, Thomas ED. Anti-leukemic effect of chronic graft-versus-host disease. N Engl J Med 1981; 304:1529-33.
35. Urbano-Ispizua A, Rozman C, Martínez C, et al. Rapid engraftment without significant GVHD after allogeneic transplantation of CD34+ selected cells from peripheral blood. Blood 1997; 89:3967-77.
36. Bensinger WI, Buckner CD, Shanon-Dorcy K, et al. Transplantation of allogeneic CD34+ peripheral blood stem cells in patients with advanced hematologic malignancy. Blood 1996; 88:4132-8.
37. Finke J, Brugger W, Bertz H, et al. Allogeneic transplantation of positively selected peripheral blood CD34+ progenitor cells from matched related donors. Bone Marrow Transpl 1996; 18:1081-6.
38. Ruutu T, Volin L, Elonen E. Low incidence of severe acute and chronic graft-versus-host disease as a result of prolonged cyclosporine prophylaxis and early aggressive treatment with corticosteroids. Transplant Proc 1988; 20:491-3.
39. Bacigalupo A, Majolino A, Van Lint MT, et al. Cyclosporin A and chronic graft versus host disease. Bone Marrow Transpl 1990; 6:341-4.